ANIMATE: Phase II Study of Nivolumab Monotherapy for Relapsed/Refractory Hodgkin Lymphoma
Clinical trial NCT03337919 · UNKNOWN
Trial details
- NCT number
- NCT03337919
- Sponsor
- University College, London
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-03
- Primary completion
- 2023-03-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.